Search for: "Apotex" Results 541 - 560 of 1,051
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jun 2008, 3:22 am
  Other companies in the second wave included Lek Pharmaceutical, Apotex, and Impax Labs. [read post]
1 Dec 2010, 12:15 am by Kelly
TM 216996 – Schering Plough (The IP Factor) Concerta (Methylphenidate) – US: Impax Laboratories confirms patent suit relating to generic Concerta 54 mg tablets (SmartBrief) Hycamtin (Topotecan) – US: APP Pharmaceuticals announces approval and launch of Topotecan for injection (SmartBrief) Lovaza (Omega-3) – US: Pronova Biopharma receives Lovaza paragraph IV notice letter from Apotex Inc (GenericsWeb) Naropin (Ropivacaine) – UK: Assigned or not? [read post]
12 Oct 2010, 8:56 pm by Kelly
Eisai Co (Orange Book Blog) (FDA Law Blog) (Patently-O) Azilect (Rasagiline) – US: Teva files patent infringement suits against Mylan and Watson in response to Para IV certification (Patent Docs) Boniva (Ibandronic acid) – US: Roche Boniva patent dispute with Apotex, Cobalt goes to jury (Patent Docs) Cozaar (Losartan) / Hyzaar (Losartan, Hydrochlorothiazide) – US: It lives!! [read post]
14 Nov 2008, 2:08 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Plavix (Clopidogrel) - Canada: Selection patents upheld by Supreme Court: Apotex v Sanofi-Synthelabo Canada (Jeremy de Beer) (ipblog.ca) (Excess… [read post]
30 Dec 2009, 2:00 am
(Ills, Pills And Attendant Thrills) India and UK: NICE, Nexavar, and why it matters (Ills, Pills And Attendant Thrills) (Spicy IP) Israel: State of Israel sues Omrix, which commercialises medical adhesives, for half a billion, claiming that their IP is based on service inventions belonging to the State (IP Factor) Kenyan anti-counterfeiting law to face constitutional challenge (Michael Geist) (Afro-IP) US: Monsanto announces new policy regarding Roundup Ready Seeds (Patent Docs)   Products… [read post]
16 Jun 2010, 10:30 am by FDABlog HPM
SA4361 and its predecessors appear to be rooted in a paper Apotex issued early last year. [read post]
26 May 2007, 11:26 pm
District Judge Sid ney Stein in Manhattan could make a decision any day.Spokesmen for Bristol-Myers, Sanofi and Apotex all declined to comment. [read post]
19 May 2011, 6:49 pm by Rantanen
  The district court found all the patents nonobvious following a bench trial and Apotex stipulated to infringement. [read post]
3 Apr 2017, 7:03 am by Joy Yusi
Ontario stripping Tarion of builder regulator role Diamond & Diamond personal injury lawyers say Bill 103 leaves victims out in the coldEditorial: Canadian press freedoms are not negotiableHawaii Judge Extends Order Blocking Trump’s Travel BanNorth Carolina lawmakers approve repeal of controversial bathroom billTrump takes 1st step in NAFTA renegotiation: Sends draft letter to CongressReal estate lawyers say new regulator will better protect Ontario home buyers - Toronto - CBC NewsSeattle… [read post]
3 Apr 2013, 4:45 am by Eric Guttag
Sheridan) ruled against the company on the issue of patent infringement in its suit against Apotex Inc. [read post]
16 May 2014, 4:42 am by Lawrence B. Ebert
Apotex, Inc., 480 F.3d 1348, 1361 (Fed. [read post]
21 Nov 2012, 11:35 pm by Michael Geist
The decision has already had considerable fallout, as Pfizer has asked for a rehearing, had the patent confirmed as invalid in a Federal Court case with Apotex, and dropped its retail price to match the generic pricing. [read post]
28 Feb 2013, 7:46 am
  Eli Lilly has sued alleging infringement of the patented ALIMTA before:  ·         Eli Lilly Sues Apotex Inc. for Patent Infringement of ALIMTA   ·         Eli Lilly and Company Sues Accord Healthcare for Patent Infringement of Lung Cancer Drug ALIMTA ·         Lilly Wins Patent Infringement Suit Regarding Chemotherapy Drug … [read post]
9 Jul 2017, 1:11 am by Mark Summerfield
  One further step in that direction was taken by the Canadian Supreme Court on 30 June 2017, when it banished the so-called ‘Promise Doctrine’ of inutility from Canadian patent law: AstraZeneca Canada Inc v Apotex Inc 2017 SCC 36. [read post]
8 Jul 2009, 7:04 am
– CAFC decision in Agilent Techs v Affymetrix concerning claims pertaining to ‘microarray hybridization’ (Gray on Claims) US: Counterclaims dismissed in Alzheimer’s Institute/ Mayo patent licensing dispute over transgenic mice (Patent Docs)   Products (Tavanic) Levofloxacin – UK: EWCA upholds decision that Daiichi’s Levofloxacin patent and SPC both invalid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd and Daiichi Sankyo Co Ltd… [read post]
14 May 2015, 4:00 am by Paula Bremner
In Apotex v Pfizer Canada, 2014 FCA 250 [celecoxib NOC case], The Court of Appeal was focussed on interpreting the Promise in favour of Pfizer. [read post]
15 Oct 2019, 2:09 am by Courtenay C. Brinckerhoff
Apotex, Inc., the Federal Circuit reversed the PTAB’s determination that a Tarceva® patent was invalid as obvious because the decision was not supported by a reasonable expectation of success. [read post]